Quertle Releases BioAI™ — The First Biomedical Big Data and Artificial Intelligence Platform for …

HENDERSON, Nev.–(BUSINESS WIRE)–Quertle LLC has developed the first artificial intelligence and visual analytics big data (BioAI™) platform for biomedical drug discovery. This platform combines machine learning, neural networks, and other AI methods to improve discovery and insight. The BioAI™ platform includes predictive visual analytics that accelerate search and discovery from the literature, enable discovery of documents that are otherwise overlooked and improve drug discovery. The AI-powered visualizations summarize an entire set of documents, detect trends and uncover hidden connections. Biomedical literature is the foundation of the $5 trillion health care market, serving as the basis for drug discovery, medical device opportunities, marketing decisions and direct health care. Yet, effective use of this literature has remained elusive. Standard search technology is inadequate — missing big data analytics, visualizations and AI. In…


Link to Full Article: Quertle Releases BioAI™ — The First Biomedical Big Data and Artificial Intelligence Platform for …